Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totalling 54,300 shares, a decrease of 55.7% from the August 31st total of 122,600 shares. Approximately 0.3% of the shares of the stock are short sold. Based […]
Form 8-K Pasithea Therapeutics For: Sep 14 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The Psychedelics Stock Universe Is Shrinking, Despite the Hype bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.